SCHEMBL10132597

SCHEMBL10132597

COc1cc2c(NC(=O)c3c(Br)ccc4c3OCO4)cccc2c(-c2ccc(-c3ccccc3)cc2)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.45
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TARBP2 Q15633 2/20 0.39
ABCB1 P08183 5/20 0.39
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132615 0.98 RXFP1 (0.46) RXFP1NPC1RAB9AMAPTHPGD
SCHEMBL10132634 0.93 RXFP1 (0.45) RXFP1NPC1RAB9AMAPTHPGD
SCHEMBL10132623 0.85 ALDH1A1 (0.42) NPC1RAB9AMAPTHPGDKDM4E
SCHEMBL10161769 0.85 ABCB1 (0.44) RXFP1MAPTKDM4EHSD17B10LMNA
SCHEMBL420470 0.84 MAPT (0.44) RXFP1NPC1RAB9AMAPTHPGD
SCHEMBL10132642 0.83 SMO (0.43) RXFP1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL10163103 0.83 LMNA (0.43) RXFP1MAPTHPGDKDM4EHSD17B10
SCHEMBL10132591 0.83 NPSR1 (0.42) RAB9AMAPTKDM4EALDH1A1LMNA
SCHEMBL10132694 0.81 PKM (0.42) RXFP1HPGDKDM4EHSD17B10LMNA
SCHEMBL10132602 0.81 NPSR1 (0.43) RAB9AMAPTHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH RXFP1 762/4885NPC1 2668/4885RAB9A 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.